What's breaking now, across thousands of outlets.
A personalized melanoma vaccine, called intismeran, could mark a major advance in cancer treatment. Last week, pharmaceutical companies Merck and Moderna announced clinical trial results showing the vaccine, combined with immunotherapy, reduced the risk of cancer returning or death by 42% compared with immunotherapy alone.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Landmark contract implementation drove 11% revenue growth and margin expansion.
International travel used to be the main risk of measles cases in the US—not anymore.
International travel used to be the main risk of measles cases in the US—not anymore.
A new study by researchers at Bournemouth University has shown that autistic people consistently experience more severe menopausal symptoms than non-autistic people, leading to poorer well-being and…
Anthony Edwards was among the NBA’s leading scorers through the first week of the season, and he was helping make the Minnesota Timberwolves the most exciting team in the league.
Many jurisdictions have started to change the rules on diagnosing the disorder, allowing local doctors to play a more central role in care Get our breaking news email , free app or daily news podcast…
